SCHEMBL12469077

SCHEMBL12469077

Cc1oc(-c2ccc(N(Cc3cccnc3)C(=O)C(F)(F)F)cc2)nc1CS(=O)(=O)C1CCC(N2CCCC2)CC1

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HTT P42858 3/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
LMNA P02545 2/20 0.41
GALR3 O60755 1/20 0.41
ALDH1A1 P00352 4/20 0.38
PDK1 Q15118 4/20 0.38
TSHR P16473 2/20 0.38
MAPK1 P28482 1/20 0.37
KDM4E B2RXH2 2/20 0.37
USP2 O75604 1/20 0.37
CYP3A4 P08684 1/20 0.36
POLB P06746 1/20 0.36
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12469073 0.99 HTT (0.40) HTTMEN1KMT2AL3MBTL1SMN1; SMN2
SCHEMBL15419507 0.89 MEN1 (0.40) HTTMEN1KMT2AL3MBTL1SMN1; SMN2
SCHEMBL12468783 0.88 MEN1 (0.40) HTTMEN1KMT2AL3MBTL1SMN1; SMN2
SCHEMBL15419531 0.86 HTT (0.39) HTTMEN1KMT2AL3MBTL1SMN1; SMN2
Trifluoroacetic Acid SCHEMBL12469074 0.82 MAPT (0.51) HTTMEN1KMT2AL3MBTL1SMN1; SMN2
Trifluoroacetic Acid SCHEMBL12469071 0.81 MAPT (0.51) HTTMEN1KMT2AL3MBTL1SMN1; SMN2
SCHEMBL15325975 0.80 MAPT (0.54) HTTMEN1KMT2AL3MBTL1SMN1; SMN2
SCHEMBL12468995 0.80 MAPT (0.54) HTTMEN1KMT2AL3MBTL1SMN1; SMN2
SCHEMBL15325980 0.80 MAPT (0.54) HTTMEN1KMT2AL3MBTL1SMN1; SMN2
SCHEMBL15325983 0.80 MAPT (0.53) HTTMEN1KMT2AL3MBTL1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150329503-A1 SUBSTITUTED BENZAMIDES AND THEIR USES UNIV LELAND STANFORD JUNIOR (US) 2015-11-19 US disclosed
US-9085570-B2 Substituted benzamides and their uses THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2015-07-21 US disclosed
US-20150072976-A1 SUBSTITUTED BENZAMIDES AND THEIR USES ARAVIVE BIOLOGICS, INC. 2015-03-12 US disclosed
EP-2838534-A2 SUBSTITUTED BENZAMIDES AND THEIR USES The Board of Trustees of The Leland Stanford Junior University (US) 2015-02-25 EP disclosed
US-20140024649-A1 Substituted Benzamides and Their Uses AUCKLAND UNISERVICES LIMITED (NZ) 2014-01-23 US disclosed
WO-2013155338-A2 SUBSTITUTED BENZAMIDES AND THEIR USES THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2013-10-17 WO disclosed
EP-2627324-A2 SUBSTITUTED BENZAMIDES AND THEIR USES The Board of Trustees of The Leland Stanford Junior University (US) 2013-08-21 EP disclosed
WO-2012051117-A2 SUBSTITUTED BENZAMIDES AND THEIR USES THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) 2012-04-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150329503-A1 SUBSTITUTED BENZAMIDES AND THEIR USES NISCH, BTD, NAAA HTT 1666/4885MEN1 2797/4885KMT2A 459/4885
US-20140024649-A1 Substituted Benzamides and Their Uses NISCH, BTD, NAAA HTT 1666/4885MEN1 2797/4885KMT2A 459/4885
US-20150072976-A1 SUBSTITUTED BENZAMIDES AND THEIR USES NISCH, BTD, NAAA HTT 1666/4885MEN1 2797/4885KMT2A 459/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.